Cota Capital and Section 32 join as investors to support the launch of the Miro Canvas, Miroculus’ first commercial platform. Miroculus, Inc., a developer of revolutionary tools for personal lab automation, today announced the completion of a Series B extension, bringing the total capital raised in the series to $45M. “This round of financing will […]
INTEGRA Biosciences AG – based in Zizers, Switzerland and Hudson, New Hampshire – has released its 2020 annual report, with sales rising 73% compared to the previous year for this manufacturer of laboratory equipment and pipettes. This is the tenth straight year of sales growth for this hidden champion from the Chur Rhine Valley. Reporting sales of […]
Polymer Factory Sweden AB today announces that Spotlight Stock Market’s listing committee has approved Polymer Factory’s application for admission to trading of the Company’s shares and warrants on Spotlight Stock Market. Polymer Factory is, prior to the planned listing, conducting an issue of units (shares and free of charge warrants) amounting to a total of […]
Funding by CVC Credit has supported five acquisitions since June 2020 CVC Credit is pleased to announce that it has further supported life sciences and diagnostics business, Calibre Scientific, by leading an incremental $57 million multicurrency first lien credit facility to help fuel its ongoing global acquisition strategy. Calibre Scientific is owned by investment firm […]
SEATTLE — Phase Genomics, Inc., the biotech leader providing proximity-ligation solutions for the genomics community, announced today the receipt of a $1.7MM grant from the National Institute of Allergy and Infectious Diseases (NIAID). This funding will fuel the commercialization of a first-in-class solution for the discovery of DNA viruses, employing a novel reagent kit and […]
Newcastle-based human stem cell model specialists, Newcells Biotech, have secured a total of £5.25m worth of funding to accelerate their growth plans in the international life sciences market. The funding comes from two existing backers. Mercia has invested from its Northern Venture Capital Trust (VCT) and EIS funds and the North East Venture Fund (NEVF), which is […]
WOBURN, Mass. — ABclonal Biotechnology, a global life science tools and services provider, recently completed its $92.9 million Series C financing led by Sequoia Capital China and healthcare-focused investor LYFE Capital. Other new and existing shareholders, such as Sigma Square Capital, Kinghall Ventures, and Lucion Capital, participated in the new round. ABclonal Biotechnology, parent company of Massachusetts-based life […]
Orders for the company’s AQS3pro™ platform grew over 500% in the second full year since product launch, and the company closed a $6.4 million Series D Preferred Stock extension to support continued aggressive growth in 2021. Burlington, MA – February 18th, 2021 RedShift BioAnalytics, Inc. (www.redshiftbio.com), a provider of innovative analytical solutions for protein characterization used […]
HighCape Capital Acquisition Corporation The transaction will merge Quantum-Si’s revolutionary, end-to-end proteomics solution, and HighCape Capital Acquisition Corp., a healthcare-focused SPAC sponsored by leading healthcare growth equity investment firm HighCape Capital LP. The transaction is further supported by an oversubscribed $425 million PIPE with participation from leading institutional investors, including Foresite Capital Management, LLC, Eldridge, […]
Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery process CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced it has raised significant investment from Kester Capital, a leading UK mid-market private equity firm typically investing between £10 to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
